首页> 外国专利> still for framstellning of new antitumorantibiotika, called aklacinomycin (a) and (b), by the cultivation of a strain of streptomyces galilaeus

still for framstellning of new antitumorantibiotika, called aklacinomycin (a) and (b), by the cultivation of a strain of streptomyces galilaeus

机译:仍用于通过培养一株半乳链霉菌菌株来对新的称为aklacinomycin(a)和(b)的抗肿瘤抗生物素进行鉴定。

摘要

New antitumor agents named aclacinomycins A and B, which are anthracycline glycosides and inhibit the growth of various microorganisms e.g., Staphylococcus aureus, Micrococcus flavus, Corynebacterium bovis and inhibit the growth of animal tumors such as leukemia L1210 and P388 and lymphoma 6C3HED in mice and hepatomas in rats are produced by the fermentation of a microorganism belonging to the genus Streptomyces which has been designated Streptomyces galilaeus (MA144-M1 and A.T.C.C. 31133); they are recovered from the broth by conventional methods for recovering antibiotics.
机译:新型抗肿瘤药称为阿克拉霉素A和B,它们是蒽环类苷,可抑制各种微生物(例如金黄色葡萄球菌,黄微球菌,牛棒状杆菌)的生长,并抑制动物肿瘤(例如白血病L1210和P388和淋巴瘤6C3HED)在小鼠和肝癌中的生长。在大鼠中,通过发酵属于链霉菌属的微生物被生产,该微生物已被命名为半乳链霉菌(Streptomyces galilaeus)(MA144-M1和ATCC 31133);通过常规的抗生素回收方法从肉汤中回收它们。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号